Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Non small cell lung cancer is a type of cancer that commonly affects the lungs and spreads more slowly than its counterpart, small cell lung cancer. This particular form accounts for about 85% of all lung cancers, making it the most prevalent subtype. Non small cell lung cancer can be further categorized into three main types: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma often starts in cells that produce mucus and is typically found on the outer parts of the lungs. Squamous cell carcinoma usually arises in the lining of bronchial tubes and tends to cause symptoms like coughing or shortness of breath earlier on. Large cell carcinoma refers to tumors that are difficult to classify as either adenocarcinoma or squamous cell carcinoma due to their unique characteristics. Although non small cell lung cancer progresses at a slower pace, proper diagnosis at an early stage remains vital for effective treatment options such as surgery, radiation therapy, chemotherapy, targeted therapies or immunotherapy tailored according to individual cases and preferences.
1.
New policy review highlights the importance of health-related quality of life in advanced cancer
2.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
3.
Study identifies new target for obesity-related breast cancer
4.
Novel Agent Effective for Cancer Wasting Disorder
5.
The response of bipolar patients to lithium may be predicted by ancestry.
1.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
2.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
3.
Integrated Updates in Oncology for Specialists
4.
Pediatric Advances in Mapping Hematopoietic Development During Childhood
5.
The Importance of Balanced Potassium Levels in Maintaining Good Health
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
2.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge